Quality control of fifteen probiotic products containing Saccharomyces boulardii

Journal of Applied Microbiology

Volumn 109, Issue 5, 2010, Pages 1745-1752

  Vanhee, L M E ^a   Goeme F ^a   Nelis, H J ^a   Coenye, T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Microsatellite analysis; Probiotic; Quality control; Saccharomyces boulardii; Solid phase cytometry

Indexed keywords

CELLS; CYTOLOGY; DNA SEQUENCES; QUALITY ASSURANCE; YEAST;

CYTOMETRY; GASTRIC CONDITIONS; MICROSATELLITES ANALYSIS; PROBIOTIC PRODUCTS; PROBIOTICS; SACCHAROMYCES; SACCHAROMYCES BOULARDII; SOLID PHASIS; SOLID-PHASE; SOLID-PHASE CYTOMETRY;

QUALITY CONTROL;

ANTEDIA; BOULARDI; DIACLO; ENTERIPHAR; ENTEROL; ERCEFLORA SUPRA; GISOL; IMUTIS; OMNIFLORA AKUT; OPTIBAC; OPTIBAK; PROBIOTIC AGENT; SACCHIFLORA; ULTRA LEVURE; UNCLASSIFIED DRUG; WAPITI DARMBALANS;

CYTOLOGY; GENETIC MARKER; QUALITY CONTROL; RELATIVE HUMIDITY; YEAST;

ARTICLE; CELL COUNT; CELL SURVIVAL; CELL VIABILITY; DRUG QUALITY; DRUG STORAGE; FUNGAL CELL; FUNGAL STRAIN; FUNGUS IDENTIFICATION; HUMIDITY; NONHUMAN; QUALITY CONTROL; SACCHAROMYCES BOULARDII; STORAGE TEMPERATURE;

SACCHAROMYCES; SACCHAROMYCES BOULARDII;

EID: 78650438674     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2010.04805.x     Document Type: Article

References (28)

1. Blehaut, H., Massot, J., Elmer, G.W. and Levy, R.H. (1989) Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 10, 353-364.
2. Boddy, A.V., Elmer, G.W., McFarland, L.V. and Levy, R.H. (1991) Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats. Pharm Res 8, 796-800.
3. Buts, J.-P. and De Keyser, N. (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51, 1485-1492.
4. Buts, J.-P., Bernasconi, P., Vaerman, J.-P. and Dive, C. (1990) Stimulation of IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 35, 251-256.
5. Buts, J.-P., De Keyser, N., Marandi, S., Hermans, D., Sokal, E.M., Chae, Y.-H.E., Lambotte, L., Chanteaux, H. et al. (1999) Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut 45, 89-96.
6. Catala, P., Parthuisot, N., Bernard, L., Baudart, J., Lemarchand, K. and Lebaron, P. (1999) Effectiveness of CSE to counterstain particles and dead bacterial cells with permeabilised membranes: application to viability assessment in waters. FEMS Microbiol Lett 178, 219-226.
7. Cetina-Sauri, G. and Sierra Basto, G. (1994) Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Ann Ped 41, 397-400.
8. Cimon, B., Symoens, F., Zouhair, R., Chabasse, D., Nolard, N., Defontaine, A. and Bouchara, J.-P. (2001) Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients. J Med Microbiol 50, 367-374.
9. Czerucka, D., Nano, J.L., Bernasconi, P. and Rampal, P. (1989) Effect of Saccharomyces boulardii on cholera toxin-induced cAMP levels in rat epithelial intestinal cell lines. Gastroenterol Clin Biol 3, 383-387.
10. Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S.G. and Stateva, L. (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73, 2458-2467.
11. Elmer, G.W. and Corthier, G. (1991) Modulation of Clostridium difficile induced mortality as a function of the dose and viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice. Can J Microbiol 37, 315-317.
12. Elmer, G.W., McFarland, L.V., Surawicz, C.M., Dankos, L. and Greenberg, R.N. (1999) Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 13, 1663-1668.
13. Fietto, J.L.R., Araújo, R.S., Valadão, F.N., Fietto, L.G., Brandão, R.L., Neves, M.J., Gomes, F.C.O., Nicoli, J.R. et al. (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50, 615-621.
14. Gedek, B.R. (1999) Adherence of Escherichia coli serogroup O157 and the Salmonella Thyphimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42, 261-264.
15. Graff, S., Chaumeil, J.-C., Boy, P., Lai-Kuen, R. and Charrueau, C. (2008a) Formulations for protecting the probiotic Saccharomyces boulardii from degradation in acidic condition. Biol Pharm Bull 31, 266-272.
16. Graff, S., Chaumeil, J.-C., Boy, P., Lai-Kuen, R. and Charrueau, C. (2008b) Influence of pH conditions on the viability of Saccharomyces boulardii yeast. J Gen Appl Microbiol 54, 221-227.
17. Hennequin, C., Thierry, A., Richard, G.F., Lecointre, G., Nguyen, H.V., Gaillardin, C. and Dujon, B. (2001) Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 39, 551-559.
18. Höchter, W., Chase, D. and Hagenhoff, G. (1990) Saccharomyces boulardii in acute adult diarrhea: efficacy and tolerance of treatment. Münch Med Wochenschr 132, 188-192.
19. Malgoire, J.Y., Bertout, S., Renaud, F., Bastide, J.M. and Mallié, M. (2005) Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism. J Clin Microbiol 43, 1133-1137.
20. McCullough, M.J., Clemons, K.V., McCusker, J.H. and Stevens, D.A. (1998) Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J Clin Microbiol 36, 2613-2617.
21. McFarland, L.V. and Bernasconi, P. (1993) Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6, 157-171.
22. Mignon-Godefroy, K., Guillet, J.G. and Butor, C. (1997) Solid phase cytometry for detection of rare events. Cytometry 27, 336-344.
23. Mitterdorfer, G., Mayer, H.K., Kneifel, W. and Vierstein, H. (2002) Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. J Appl Microbiol 93, 521-530.
24. Posteraro, B., Sanguinetti, M., Romano, L., Torelli, R., Novarese, L. and Fadda, G. (2005) Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae. Int J Food Microbiol 103, 295-304.
25. Pothoulakis, C. (2009) Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther 30, 826-833.
26. Surawicz, C.M., Elmer, G.W., Speelman, P., McFarland, L.V., Chinn, J. and Van Belle, G. (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterolgy 96, 981-988.
27. Szajewska, H., Setty, M., Mrukowicz, J. and Guandalini, S. (2006) Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 42, 454-475.
28. Van der Aa Kühle, A. and Jespersen, L. (2003) The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst Appl Microbiol 26, 564-571.